Bafilomycin a1 - OmicsDI

Show results for

Unknown (618)
Transcriptomics (20)
Proteomics (17)
Genomics (14)
Metabolomics (4)

Organisms

Homo sapiens (19)
Andropogon gerardi (14)
Bacteria (14)
Canis lupus familiaris (14)
Clostridium perfringens (14)
Cnidaria (14)
Cricetulus griseus (14)
Eukaryota (14)
Fasciola (14)
Hepatitis B virus (14)
Human betaherpesvirus 5 (14)
Madurella mycetomatis (14)
Mesocricetus auratus (14)
Miscanthus x giganteus (14)
Mus musculus (14)
Mycobacterium tuberculosis (14)
Orthoflavivirus (14)
Panicum virgatum (14)
Platyhelminthes (14)
Pseudomonas aeruginosa AES-1R (14)
Rattus norvegicus (14)
Saccharomyces cerevisiae (14)
Schizosaccharomyces pombe (14)
Severe acute respiratory syndrome coronavirus 2 (14)
Shigella (14)
Sorghastrum nutans (14)
Streptococcus dysgalactiae subsp. equisimilis SK1249 (14)
Streptococcus pneumoniae (14)
Mus musculus (3)
Trichinella spiralis (1)

Organisms

Homo sapiens (12)
Mus musculus (1)

Repository

pride (14)
ENA (14)
geo (11)
biostudies-arrayexpress (9)
iProX (3)
MetabolomicsWorkbench (2)
GNPS (1)
MetaboLights (1)

Tissue

Cell culture (4)
Brain (3)
Mesenteric lymph (2)
Permanent cell line cell (2)
Astrocyte (1)
Blood (1)
Blood cell (1)
Blood plasma (1)
Early embryonic cell (1)
Fibroblast (1)
HEK-293 cell (1)
Hepatocyte (1)
Myeloblast (1)
Oocyte (1)
Primary cell (1)
T-24 cell (1)
Urinary bladder carcinoma cell line (1)

Disease

Obesity (1)
Diabetes (1)
Acute myeloid leukemia (1)
Alzheimer's disease (1)
Brain glioblastoma multiforme (1)
Colorectal cancer (1)

Technology Type

Mass Spectrometry (16)
Shotgun proteomics (9)
Bottom-up proteomics (4)
ESI (2)
Affinity purification coupled with mass spectrometry proteomics (2)
Data-dependent acquisition (2)
Mass spectrometry (1)
Data-independent acquisition (1)
SomaScan affinity proteomics (1)

Instrument Platform

Q Exactive (1)
Liquid Chromatography MS - alternating - reverse phase (1)

Publication Date

2025 (7)
2024 (5)
2026 (4)
2023 (4)
2014 (3)
2013 (3)
2020 (3)
2015 (2)
2012 (2)
2022 (2)
2008 (1)
2019 (1)
2021 (1)
2016 (1)

CHEBI ID

CHEBI:17084 (1)

Metabolite Name

2-Hydroxyglutarate (1)

First Public Date

2025 (3)
2024 (3)
2014 (3)
2026 (2)
2019 (1)
2018 (1)
2015 (1)

Study type

Transcription profiling by array (7)
ChIP-chip by tiling array (1)
RNA-seq of coding RNA (1)

Release Date

2021 (85)
2025 (70)
2020 (70)
2022 (65)
2023 (59)
2019 (47)
2024 (43)
2018 (35)
2017 (33)
2015 (30)
2016 (25)
2014 (17)
2013 (13)
2012 (8)
2011 (6)
2009 (5)
2010 (4)
2008 (3)
2006 (3)
2026 (2)
2005 (2)
2004 (2)

Lab affiliation

Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, Spain. (1)
Deparment of Biochemistry and Molecular Biology, University of British Columbia, Canada (1)
Department of Proteomics and Signal Transduction, Systems Biology of Membrane Trafficking Research Group, Max-Planck Institute of Biochemistry, Martinsried, Germany (1)
Dept. of Biology University of Fribourg Chemin du Musee 10 CH-1700 Fribourg Switzerland (1)
Institute of Biochemistry II, Goethe University Frankfurt, Germany (1)
Max Delbrueck Centrum, Berlin Charité, Berlin (1)
Proteomics & Metabolomics Facility, MRC London Institute of Medical Sciences, Du Cane Road, London W12 0NN, United Kingdom (1)
QBI Director and Professor in Cellular and Molecular Pharmacology, UCSF (1)
S. Robert Davis Chair of Medicine Professor and Chair, Department of Internal Medicine Director, Medical Scientist Training Program (1)
Target Discovery Institute, Nuffield Dept Medicine, University of Oxford, UK (1)
The Proteomics Facility of the University of Bergen (PROBE), The Department of Biomedicine, University of Bergen, Bergen, Norway (1)
Unité Toxicologie des contaminants ANSES – Laboratoire de Fougères 10 B rue Claude Bourgelat – Javené - CS 40608 35306 FOUGERES Cedex FRANCE (1)
University of Vienna, Faculty of Chemistry, Department of Analytical Chemistry (1)
Winter Lab, CeMM Research Center for Molecular Medicine of the Austrian Academy of Sciences, Vienna, Austria (1)

Tags

xref:PubMed:31983508 (1)
xref:PubMed:21730326 (1)
xref:PubMed:38262111 (1)
xref:PubMed:40920489 (1)
xref:PubMed:23469216 (1)
xref:PubMed:26404941 (1)
xref:PubMed:24548329 (1)

Previous page
1 / 68
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 68
Next page

Sort by:

Relevance

Page size

Human colon carcinoma cell line treated with bafilomycin A1

Analysis of mRNA expression changes in human colon carcinoma cell lines (HCT116 H2B-GFP) after treatment bafilomycin A1. mRNA expression analysis of HCT116 H2B-GFP treated with bafilomycin A1 compared to untreated HCT116 H2B-GFP. Four biological replicates were performed for treated samples.

ORGANISM(S): Homo sapiens

2014-02-19 | E-GEOD-47836 | biostudies-arrayexpress

Human colon carcinoma cell line treated with bafilomycin A1

Analysis of mRNA expression changes in human colon carcinoma cell lines (HCT116 H2B-GFP) after treatment bafilomycin A1.

ORGANISM(S): Homo sapiens

2014-02-19 | GSE47836 | GEO

Distinct signal transduction pathways downstream of the (P)RR revealed by microarray and ChIP-chip analyses [Expt: Geni_Bafi]

Within the overall project, we performed a set of microarray and chromatin-immunoprecipitation (ChIP)-chip experiments using siRNA against the (pro)renin receptor ((P)RR), stable overexpression of PLZF, the PLZF translocation inhibitor genistein and the specific V-ATPase inhibitor bafilomycin to dis...

ORGANISM(S): Homo sapiens

2013-07-05 | E-GEOD-39962 | biostudies-arrayexpress

Molecular basis of V-ATPase inhibition by bafilomycin A1.

Not available

S-EPMC7979754 | biostudies-literature

Bafilomycin A1 Inhibits HIV-1 Infection by Disrupting Lysosomal Cholesterol Transport.

Not available

S-EPMC11435809 | biostudies-literature

Homo sapiens

Human colon carcinoma cell line treated with bafilomycin A1

PRJNA208119 | ENA

Bafilomycin A1 and U18666A Efficiently Impair ZIKV Infection.